Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

(2015) Can Küçük et al.   Nature Communications

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

(2014) M. J. Kiel et al.   BLOOD

Suberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia

(2014) Xiaoshen Sun et al.   BRITISH JOURNAL OF HAEMATOLOGY

The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse

(2014) O. R. Bandapalli et al.   HAEMATOLOGICA

Vorinostat Downregulates CD30 and Decreases Brentuximab Vedotin Efficacy in Human Lymphocytes

(2014) Z. S. Hasanali et al.   MOLECULAR CANCER THERAPEUTICS

Central Nervous System Involvement of T-cell Prolymphocytic Leukemia Diagnosed with Stereotactic Brain Biopsy: Case Report

(2014) Selçuk Göçmen et al.   Turkish Journal of Hematology

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

(2013) H. L. M. Rajala et al.   BLOOD

Recruitment and Biological Consequences of Histone Modification of H3K27me3 and H3K9me3

(2013) J. Kim et al.   ILAR JOURNAL

How I treat prolymphocytic leukemia

(2012) C. Dearden   BLOOD

Brentuximab vedotin

(2012) Anas Younes et al.   NATURE REVIEWS DRUG DISCOVERY

Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients

(2012) R. A. Clark et al.   Science Translational Medicine

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis

(2011) A. Cuker et al.   BLOOD

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

(2011) C. E. Dearden et al.   BLOOD

Modulation of TNFSF expression in lymphoid tissue inducer cells by dendritic cells activated with Toll-like receptor ligands

(2011) Sin-Suk Han et al.   BMB Reports

The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation

(2011) Junichi Tsukada et al.   CYTOKINE

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications

(2011) Omar Khan et al.   IMMUNOLOGY AND CELL BIOLOGY

Primary cutaneous CD30-positive anaplastic large cell lymphoma in a 16-year-old girl

(2011) Engin Kocabaş et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients

(2011) Akihiko Yokohama et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Mastocytosis: the new differential diagnosis of CD30-positive neoplasms

(2011) Irina Maric et al.   LEUKEMIA & LYMPHOMA

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma

(2010) V. V. Leshchenko et al.   BLOOD

Serial Soluble CD30 Measurements as a Predictor of Kidney Graft Outcome

(2010) M.A. Halim et al.   TRANSPLANTATION PROCEEDINGS

A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry

(2009) Reid F. Thompson et al.   BIOINFORMATICS

Cladribine: not just another purine analogue?

(2009) Stephen Spurgeon et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Activated Effector and Memory T Cells Contribute to Circulating sCD30: Potential Marker for Islet Allograft Rejection

(2008) D. Saini et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Critical Role for Transcription Factor C/EBP-  in Regulating the Expression of Death-Associated Protein Kinase 1

(2008) P. Gade et al.   MOLECULAR AND CELLULAR BIOLOGY